Redefining the overlap of asthma and COPD

    Insights

    Asthma-COPD overlap (ACO) describes patients with airflow obstruction sharing features of both asthma and COPD. Management remains unclear despite worse outcomes for these patients.

    Area of Science:

    • Pulmonology
    • Respiratory Medicine

    Background:

    • Asthma-COPD overlap (ACO) identifies patients with chronic airflow obstruction exhibiting characteristics of both asthma and chronic obstructive pulmonary disease (COPD).
    • Patients with ACO often experience poorer health outcomes compared to those with asthma or COPD alone.
    • Current UK guidelines lack specific recommendations for managing ACO, highlighting a clinical management gap.

    Purpose of the Study:

    • To explore the challenges associated with managing patients who have asthma-COPD overlap.
    • To discuss the diagnostic and treatment considerations for this heterogeneous patient group.

    Main Methods:

    • Review of current literature and guidelines regarding asthma, COPD, and ACO.
    • Analysis of consensus-based reports from organizations like GINA and GOLD.
    • Discussion of clinical management strategies for patients with overlapping asthma and COPD features.

    Main Results:

    • The term ACO is preferred over ACOS (asthma-COPD overlap syndrome) to avoid implying a single disease entity.
    • ACO represents a heterogeneous group of patients with complex respiratory conditions.
    • There is a need for clearer diagnostic criteria and tailored management plans for ACO.

    Conclusions:

    • Managing asthma-COPD overlap presents significant challenges due to its heterogeneous nature.
    • Further research and guideline development are necessary to optimize care for ACO patients.
    • Collaboration between asthma and COPD management strategies is crucial for this patient population.

    Related Concept Videos

    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    950
    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    2.8K
    Asthma-II: Pathophysiology and Classification01:26

    Asthma-II: Pathophysiology and Classification

    Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
    Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
    Critical processes in asthma pathophysiology include:
    4.7K
    Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology

    Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
    Chronic Inflammation
    4.9K